alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                                                                    EXHIBIT 23.1


                       CONSENT OF INDEPENDENT ACCOUNTANTS


The Board of Directors
Caminus Corporation:


We consent to the incorporation by reference in the registration statements on
Form S-8 (File Nos. 333-95533, 333-31004, 333-31006, 333-43378, 333-61258,
333-68616 and 333-81570) of Caminus Corporation of our report dated February 6,
2002, with respect to the consolidated balance sheets of Caminus Corporation and
Subsidiaries as of December 31, 2001 and 2000, and the related consolidated
statements of operations, stockholders' equity, and cash flows for the years
then ended, which report appears in the December 31, 2001, annual report on Form
10-K of Caminus Corporation.


                                        /s/ KPMG LLP



New York, New York
February 11, 2002
Case 1:07-cv-03362-LBS Document 2 Filed 04/27/2007 Page 1 of 1
Exhibit 32.1

CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of Woodstock Financial Group, Inc. (the Company) on Form 10-K for the period ending December 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), William J. Raike, III, Chief Executive Officer of the Company, and Melissa L. Whitley, Chief Financial Officer of the Company, respectively, do each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his and her knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                                     
|-------------------------------------
|/s/ William J. Raike, III            
|William J. Raike, III                
|President and Chief Executive Officer
|March __, 2009                       
|                                     
|/s/ Melissa L. Whitley               
|Melissa L. Whitley                   
|Chief Financial Officer              
|March __, 2009
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 1 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 2 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 3 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 4 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 5 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 6 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 7 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 8 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 9 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 10 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 11 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 12 of 13
Case 1:06-cv-14866-AKH Document 1 Filed 12/08/2006 Page 13 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 1 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 2 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 3 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 4 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 5 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 6 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 7 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 8 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 9 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 10 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 11 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 12 of 13
Case 1:06-cv-15040-AKH Document 1 Filed 12/08/2006 Page 13 of 13
#### RORIE v. BLACKWELDER

No. 177 PC.

Case below: 26 N.C. App. 195.

Petition for writ of certiorari to North Carolina Court of Appeals denied 25 August 1975.
#### IN RE GREEN

No. 2 PC.

Case below: 27 N.C. App. 555.

Petition by Julian H. Jackson for discretionary review under G.S. 7A-31 denied 6 January 1976. Motion of Julian H. Jackson to dismiss appeal for lack of substantial constitutional question allowed 6 January 1976.
#### IN RE LONG

No. 137 PC.

Case below: 25 N.C. App. 702.

Petition for writ of certiorari to North Carolina Court of Appeals denied 25 August 1975.
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 1 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 2 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 3 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 4 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 5 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 6 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 7 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 8 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 9 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 10 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 11 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 12 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 13 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 14 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 15 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 16 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 17 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 18 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 19 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 20 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 21 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 22 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 23 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 24 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 25 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 26 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 27 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 28 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 29 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 30 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 31 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 32 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 33 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 34 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 35 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 36 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 37 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 38 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 39 of 40
Case 1:07-cv-03371-RPP Document 1 Filed 04/27/2007 Page 40 of 40
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               DEC-31-1997
<EXCHANGE-RATE>                                      1
<CASH>                                           2,381
<SECURITIES>                                         0
<RECEIVABLES>                                   18,681
<ALLOWANCES>                                         0
<INVENTORY>                                     17,502
<CURRENT-ASSETS>                                42,054
<PP&E>                                          42,368
<DEPRECIATION>                                  25,001
<TOTAL-ASSETS>                                  17,367
<CURRENT-LIABILITIES>                           22,677
<BONDS>                                         14,337
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           192
<OTHER-SE>                                      33,428
<TOTAL-LIABILITY-AND-EQUITY>                    74,622
<SALES>                                         31,623
<TOTAL-REVENUES>                                31,623
<CGS>                                           13,039
<TOTAL-COSTS>                                   13,039
<OTHER-EXPENSES>                                 3,927
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 315
<INCOME-PRETAX>                                  1,636
<INCOME-TAX>                                       540
<INCOME-CONTINUING>                              1,096
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,096
<EPS-PRIMARY>                                      .14
<EPS-DILUTED>                                      .14
        

</TABLE>
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 1 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 2 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 3 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 4 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 5 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 6 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 7 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 8 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 9 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 10 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 11 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 12 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 13 of 14
Case 1:07-cv-03434-GBD Document 1-3 Filed 04/30/2007 Page 14 of 14
<TABLE>
   EXHIBIT 11

   COMPUTATION OF EARNINGS (LOSS) PER SHARE

                                                                              DILUTED
                                            BASIC               
                                   Thirteen          Twenty-Six       Thirteen       Twenty-Six
                                  Weeks Ended       Weeks Ended      Weeks Ended     Weeks Ended
                                   April 25,         April 25,        April 25,        April 25,
                                     1998             1998              1998             1998
                                                                          
                     (In thousands, except per share amounts)
   <S>                                     <C>            <C>          <C>             <C>
   AVERAGE SHARES OUTSTANDING

     1  Average shares outstanding           4,300        4,300         4,300          4,300
     2  Net additional shares outstanding
         assuming exercise of stock options    -             -           -              -
     3  Average number of common shares
          outstanding                         4,300        4,300        4,300          4,300

   EARNINGS (LOSSES)

     4  Net Loss 
                                            $  (549)   $  (1,335)     $  <549>        <1,335>


   PER SHARE AMOUNTS


        Net loss
         (line 4 / line 3)                 $  (.13)        $  (.31)      <.13>          <.31>
                                                                                     



   Earnings  per  share  amounts  for  all other reporting periods as it relates  to  the
   predecessor  company  is  not meaningful due to the Company's reorganization.

   Since there is a net loss, common stock equivalents are excluded from the diluted earnings
   per share calculations since they would be antidilutive.
   
</TABLE>
UNITED STATES DISTRICT COURT 

SOUTHERN DISTRICT OF NEW YORK 

----------------Am-------------- ----- 

IN RE: Fosamax Products Liability 

Litigation, MDL No. 1763 

----------- 

This Document ReJates to: 

Eujdoso v. Mef-ol.: & Co., Inr. el- al., 

1:07-cv-P9480 (JFK) . 

Dernsk!. v. Merck & Co., Inc. et al., 

1:1:?-c~-09479 (JFK', . 

Evans v. Mel-rk & Co. , Inc. e t a2 . , 

1:07-CV-07289 (JFK) . 

Fcrrao 17. Mer-ck & Co., Inc. et al. , 

1 : (17-C-J-03294 (JFT<! . 

Finch v. Merck & Co., Tnc. et al., 

l:07-CV--09481 (JFK) . 

Goss v. Merrk & Co., Inu. et al., 

1:07-~~-0?290 (JEK) . 

Hal-ton v. Merck LC- Co., Inc. ct al., 

1 :07-CV-09482 (JFK! . 

Martin v. Merck & Co,, Inc, et: al., 

l:07-c7~--d3463 (JFK) . 

Morris v. M~rck & Co., Inc. et al., 

1 : 07-CV-01320 (JFK) . 

Moyer v. Merck & E::o., Inc. et al., 

L:L17-0-07987 TcTFK,'. 

Ceceli(3 Smi th v. Merck & Co. , I~c. et a]. , 1 :07-CV-i!9-1P-I (JFK) . 

Vasquez r-. Merck & C'o., Inc. et al. , 

i:07-cv-07295 (JFK). 

i:06-md-1785 {JFK; 

Order 

Case 1:07-cv-03294-JFK Document 34 Filed 09/11/2008 Page 1 of 2
JOHN F. KEENAN, United States District Judge: 

A pre-mfiticn conference or Merck's antlc~pated motion 

to sever cases In the ako-~e actlons will be held on Octaber 16, 

2008 at 10:?5 a.m. Plaintiffs are dlrected to sxhrnlt a letter 

t~> the Tourt stating thelr position on the motion by Oct~ber 13, 

ZGrl?. 

SO ORDERED. 

Dated: New York, New York 

September 11, 2008 

'J' JOHN F. KEENAN 

United States District Judge 

Case 1:07-cv-03294-JFK Document 34 Filed 09/11/2008 Page 2 of 2
IC 

116TH CONGRESS 

1ST SESSION S. 1749 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 10, 2019 

Referred to the Committee on Financial Services, and in addition to the Committee on Veterans’ Affairs, for a period to be subsequently determined 

by the Speaker, in each case for consideration of such provisions as fall 

within the jurisdiction of the committee concerned 

AN ACT 

To clarify seasoning requirements for certain refinanced 

mortgage loans, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


kjohnson on DSK79L0C42 with BILLS
2 

S 1749 RFH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Protecting Affordable 

3 Mortgages for Veterans Act of 2019’’. 

4 SEC. 2. SEASONING REQUIREMENTS FOR CERTAIN REFI5 NANCED MORTGAGE LOANS. 

6 (a) GINNIE MAE.—Section 306(g)(1) of the National 

7 Housing Act (12 U.S.C. 1721(g)(1)) is amended by strik8 ing the second sentence. 

9 (b) VETERANS LOANS.—Section 3709(c) of title 38, 

10 United States Code, is amended— 

11 (1) in the matter before paragraph (1), by 

12 striking ‘‘is refinanced’’ and inserting ‘‘is a refi13 nance’’; and 

14 (2) by striking paragraphs (1) and (2) and in15 serting the following new paragraphs: 

16 ‘‘(1) the date on which the borrower has made 

17 at least six consecutive monthly payments on the 

18 loan being refinanced; and 

19 ‘‘(2) the date that is 210 days after the first 

20 payment due date of the loan being refinanced.’’. 

21 (c) RULE OF CONSTRUCTION.—Nothing in this Act 

22 may be construed to restrict or otherwise modify the auVerDate Sep 11 2014 02:08 Jun 11, 2019 Jkt 089200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S1749.RFH S1749

kjohnson on DSK79L0C42 with BILLS
3 

S 1749 RFH

1 thorities of the Government National Mortgage Associa2 tion. 

Passed the Senate June 5, 2019. 

Attest: JULIE E. ADAMS, 

Secretary. 


kjohnson on DSK79L0C42 with BILLS
Case 1:07-cv-03454-DC Document 3 Filed 05/09/2007 Page 1 of 1
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                          11,351
<SECURITIES>                                         0
<RECEIVABLES>                                   44,903<F1>
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                     82,559
<CURRENT-ASSETS>                               166,551
<PP&E>                                          82,364
<DEPRECIATION>                                (38,085)
<TOTAL-ASSETS>                                 240,663
<CURRENT-LIABILITIES>                           57,552
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         9,822
<OTHER-SE>                                     124,205
<TOTAL-LIABILITY-AND-EQUITY>                   240,663
<SALES>                                        150,584
<TOTAL-REVENUES>                               150,584
<CGS>                                          104,921
<TOTAL-COSTS>                                  142,749
<OTHER-EXPENSES>                                 (306)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0<F2>
<INCOME-PRETAX>                                  8,141
<INCOME-TAX>                                     2,849
<INCOME-CONTINUING>                              5,049
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,049
<EPS-PRIMARY>                                    $0.61
<EPS-DILUTED>                                    $0.61
<FN>
<F1>Accounts Receivable, Trade are reported net of allowance for doubtful 
accounts in the Condensed Consolidated Balance Sheet.
<F2>Interest and Other, Net includes interest expense.
</FN>
        

</TABLE>
[Federal Register Volume 70, Number 227 (Monday, November 28, 2005)]
[Notices]
[Page 71378]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23299]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Office of Research and Development; Government Owned Invention 
Available for Licensing

AGENCY: Office of Research and Development, VA.

ACTION: Notice of Government owned invention available for licensing.

-----------------------------------------------------------------------

SUMMARY: The invention listed below is owned by the U.S. Government as 
represented by the Department of Veterans Affairs, and is available for 
licensing in accordance with 35 U.S.C. 207 and 37 CFR part 404 and/or 
Cooperative Research and Development Agreements (CRADA) Collaboration 
under 15 U.S.C. 3710a to achieve expeditious commercialization of 
results of federally funded research and development. Foreign patents 
are filed on selected inventions to extend market coverage for U.S. 
companies and may also be available for licensing.

FOR FURTHER INFORMATION CONTACT: Technical and licensing information on 
the invention may be obtained by writing to: Amy E. Centanni, 
Department of Veterans Affairs, Director, Technology Transfer Program, 
Office of Research and Development, 810 Vermont Avenue, NW., 
Washington, DC 20420; fax: 202-254-0255; e-mail at: 
<a href="/cdn-cgi/l/email-protection#98f9f5e1b6fbfdf6ecf9f6f6f1d8f5f9f1f4b6eef9b6fff7ee"><span class="__cf_email__" data-cfemail="09686470276a6c677d686767604964686065277f68276e667f">[email protected]</span></a>. Any request for information should include 
the Number and Title for the relevant invention as indicated below. 
Issued patents may be obtained from the Commissioner of Patents, U.S. 
Patent and Trademark Office, Washington, DC 20231.

SUPPLEMENTARY INFORMATION: The invention available for licensing is: 
U.S. Patent Application No. 11/113,786 ``Quantitation of Endothelial 
Microparticles.''

    Dated: November 18, 2005.
Gordon H. Mansfield,
Deputy Secretary of Veterans Affairs.
[FR Doc. 05-23299 Filed 11-25-05; 8:45 am]
BILLING CODE 8320-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### CARROLL v. INDUSTRIES, INC.

No. 191 PC.

No. 95 (Fall Term).

Case below: 37 N.C. App. 10.

Petition by defendant for discretionary review under G.S. 7A-31 allowed 29 August 1978.
Case 1:07-cv-03338-DLC Document 2 Filed 06/27/2007 Page 1 of 1
Exhibit 32.1


               CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1380,
     AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of ISA Internationale Inc. (the
"Company") on Form 10-KSB for the period ending September 30, 2008, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Bernard L. Brodkorb, President, Chief Executive Officer, and Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
the best of my knowledge and belief:

(1.) The report fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and

(2.) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.

By: /s/ Bernard L. Brodkorb
Bernard L. Brodkorb, President, Chief Executive Officer, and
 Chief Financial Officer

Dated: January 13, 2009
#### STATE v. HARDY

No. 41 PC.

Case below: 33 N.C. App. 722.

Petition by defendants for discretionary review under G.S. 7A-31 allowed 4 October 1977.
Exhibit 4.1
DESCRIPTION OF SECURITIES
The following is a description of the authorized securities of Assure Holdings Corp. (“Assure” or the “Company”) and does not purport to be complete.  For a complete description of the terms and provisions of such securities, refer to the Company’s Articles of Incorporation, as amended, and Bylaws, which are filed as Exhibit 3.1, 3.2, 3.3 and 3.4 to the Company’s Form S-1 filed with the U.S. Securities and Exchange Commission on December 30, 2020, and incorporated herein by reference.  This summary is qualified in its entirety by reference to these documents.
The Company’s Articles of Incorporation authorize 180,000,000 shares of common stock, $0.001 par value.  As of March 4, 2022, 12,919,666 shares of common stock were issued and outstanding.
Common Stock
We are authorized to issue up to a total of 180,000,000 shares of common stock, par value $0.001 per share.
Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of our stockholders. Holders  of our common  stock have no cumulative  voting rights. Further, holders of our common stock have no preemptive or conversion rights or other subscription  rights.
Upon  our liquidation, dissolution  or winding-up,  holders of our common  stock are entitled to share in all assets remaining  after payment of all liabilities and the liquidation preferences of any of our outstanding shares of preferred stock.
Holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our Board out of our assets which are legally available. Such dividends, if any, are payable in cash, in property or in shares of capital stock.
The holders of shares of our common stock entitled to cast at least a majority of the total votes entitled to be cast by the holders of all of our outstanding capital  stock, present  in person  or by proxy, are necessary to constitute  a quorum  at any meeting. If a quorum  is present, an action by stockholders entitled to vote on a matter  is approved  if the number  of votes cast in favor of the action  exceeds the number  of votes cast in opposition to the action.
The vote of  a majority  of  our  stock  held by shareholders present  in person  or represented  by proxy and entitled to vote at the Meeting will be sufficient to elect Directors  or to approve  a proposal.